{"name":"Direct Biologics, LLC","slug":"direct-biologics-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ExoFlo","genericName":"ExoFlo","slug":"exoflo","indication":"Osteoarthritis of the knee","status":"phase_3"}]}],"pipeline":[{"name":"ExoFlo","genericName":"ExoFlo","slug":"exoflo","phase":"phase_3","mechanism":"ExoFlo is an exosome-based therapeutic that delivers regenerative factors to promote tissue repair and reduce inflammation.","indications":["Osteoarthritis of the knee","Chronic wounds and tissue repair"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxNQjZyQkhEWV94NlotbmFQaWd1UG1sZGFmekNuQjR5Z2Y2WmNza2xielUzNk9rcE1xSldhd2ZqT2xuXzF5eml4aXhnSEtuWkhMSmZwVVcwaHp0eF9BN1hNZVdTTGhZXzBUMC1YU2xndWdTRnk1UUdXbTBVY2ZGVmU4elZheWFOTDJ2am1ULXg4czEtaWpmWjhEUmpESFdsNVZSRjNDTjFrckttLWVzblRzZjQ4azlEV1lLeWdnQ2t3VmRwVlpCUXZPNVhReHFTM2ZJYUFJRVZhbmhpaGRLMHVqOXlTWXFmalNfdTllb0pOejF4bVlLYWNF?oc=5","date":"2026-04-01","type":"trial","source":"Barchart.com","summary":"Exosomes Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Domain | DelveInsight - Barchart.com","headline":"Exosomes Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Domain | DelveInsi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNbG1COEdSbFNzOE05Z0dOODhBaFVvMUNqSTluVHdHS21Ld2RmUXZldjNHLVZHQVBiUXdMdkFLUnY3bWh2VjNiRnRsbmhqZkYteWJaU1VLdVZNbEU5T0F6eHlpeG1SSDVrWUZSQUZNbmRWdll2U2h4eWxydGZkRjkzVlc5dXlmaWNsa1pyS0FtWlRzVjdfQ3d3ejYxdzZQeTNpWWFSOXliUVl6d1hXc0NkV2Z4X2E4NXFfNHJqRFVTeDI2bjAzX1FmWVYwaWlsV3F0dmZZcG5xcXU0WUtKbmJmZlBZVnF6UXdtcUJr?oc=5","date":"2026-03-24","type":"pipeline","source":"Barchart.com","summary":"Rett Syndrome Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Barchart.com","headline":"Rett Syndrome Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTFBrNFhiOXVaT0hDdE9ET2ZLRmx3ZEZYdDhIbHNqRUh6a2V0N3RpaERPRVhlczNHU0RaZzU4YkVWTm9kODFOamlpOFNzY3BDRGZpU0F5TGpOODM2X29uR1d5dHZZUW42NEYwQ0J2WUN4UC1wX1NZaXhDLTdR?oc=5","date":"2026-01-14","type":"pipeline","source":"Fierce Pharma","summary":"JPM26, Day 3: AbbVie touts 'clear line of sight' to continued growth into 2030s - Fierce Pharma","headline":"JPM26, Day 3: AbbVie touts 'clear line of sight' to continued growth into 2030s","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQRzNLNnBWX2o4dDRINEV1cXJWLXNyd1lpYjVxdzJCQU1QelJuVWs2NzRJUVZTMzVRWXV4WHdJMFVxUk1jT0o4b2J2SXRrRXpIX0dHd0QxbGh0VmFieUc2RDVZMUV6dmVXaG0zai1Bbm1qNGxFU1hYT1hRU2hTM1NhcUVoZm5ZcGh5SlVhRGZFbVE5TEpSX0RmWTZ6MnE3YllHQWRfVnRB?oc=5","date":"2025-09-16","type":"regulatory","source":"Fierce Pharma","summary":"FDA targets Lilly, Novartis, BMS and more in deluge of marketing letters - Fierce Pharma","headline":"FDA targets Lilly, Novartis, BMS and more in deluge of marketing letters","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNdlZ0dzZjM1JudGFPeWxXSTVfejdXbWJFZjJqRGpKc1BiQmtkUlNwTlhmOVZxR19XS2t6UlU4ZFMySWg2dWxKVVZlclVhdXUxem9XMnpmcmdWTXQ1b2N4RHRjY2FpOXRwSWFEMDA3YWZfWHVIaDMzRldFdmRwLVlnZUVBd29vdzV0Y2pTQTZ4LWZJMk9VemhHRDVsem9YU2pCQTZULVVUT1VrTFVkVEp2WXNNdXYzSkxYMHJhLUZ1RQ?oc=5","date":"2025-05-22","type":"pipeline","source":"Fierce Pharma","summary":"CDMO Samsung Biologics telegraphs spinoff of biosim unit - Fierce Pharma","headline":"CDMO Samsung Biologics telegraphs spinoff of biosim unit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxPd3duWlFZcnJ5VUpJTmRLbVRGTkl2aEVHVk9JZ2lMa2h6YXNCVnQ3a0ZQZnYzVnlFQlhHdmItNGI1NUJQSTdUa0EyZFZRSWJqRTQ0dnZsZTdnZFFhNXZDdVEtNFdWclZfNmZzcE5MYXBlT2JnMmV3NVR4QWhyRlNraWZoSllBYnIxbkkwc0puUE9KWnIxcnc0QmFpeHJUN2dOeWpmTFp2TnNKU1ExZTZBdG1iN1BxWkVsM053OVppNHFkdF84V2dnUkVqQmxpeGR1S2MxZEI2MWhfczZmSnh4XzhyclQ?oc=5","date":"2024-10-29","type":"pipeline","source":"GlobeNewswire","summary":"Global Exosome Market to Surge at a Tremendous CAGR of ~20% by 2030 | DelveInsight - GlobeNewswire","headline":"Global Exosome Market to Surge at a Tremendous CAGR of ~20% by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE9NMnBaTjA0OUZnODhkWTJ1LTNnNGphVEFQbkZhd3B0MXRvTXpjWTNkUnZud1RzUWVVcnJRWTQ1UVNNZE94d0VKQ2ZhcHZSWVptM3VRWDFzVVlfYlNYZUpHbVdzRFZyUkF1TnMtVWxHYw?oc=5","date":"2024-06-30","type":"pipeline","source":"The Pharma Letter","summary":"Direct Biologics - The Pharma Letter","headline":"Direct Biologics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOdEczMWw3N2ZRNzVDNHExNHBQd25GS1p5emtXaFNBTjBZX0pTUEZHMmg1d214OHA3ZXBKcG5JaXE3amNnYnFfX2pOeDk5TURncW9yTTBxWE1BWGcxMHFLYWFNZUZScDNLdGxlUTRyNE5RSkNKQzJvdGZFdHBENl94aHlCSmxNNDRoRG1SY0ZDeHU?oc=5","date":"2024-05-02","type":"pipeline","source":"Yahoo Finance","summary":"Inflammatory Bowel Disease Market To Exhibit Significant Growth by 2032, Predicts DelveInsight | Key Companies Developing Therapies - Arena Pharmaceuticals, Pfizer, Abivax, Janssen, Celgene, Eli Lilly","headline":"Inflammatory Bowel Disease Market To Exhibit Significant Growth by 2032, Predicts DelveInsight | Key Companies Developin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNODN1R0hXaEI2X0JZVFVjU1ZEVzVLRDdrQ194OVdHcGw0b1Z1WXJOOGZBelNnR2FwSnVjdHdfUF90bWh0bzdmWnBXNE5PcnZLUG96aC1HV2hsbmRId3VIeU92VmhVaUFfYTl3UzdFMjBNbm1Dd2p2RWpueG41Y2l5TGxnY2lTSk03RjdDN1VHcHNGN210RGR4YVJtdGw?oc=5","date":"2023-06-13","type":"pipeline","source":"Dentons","summary":"In Fifth Circuit Ruling, a Stark Reminder that Preliminary Injunctive Relief may be Available to Prevent Trade Secret Misappropriation that is “Likely” to Occur - Dentons","headline":"In Fifth Circuit Ruling, a Stark Reminder that Preliminary Injunctive Relief may be Available to Prevent Trade Secret Mi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOOGtEUHFXWmhnVFd4WU9PN2RIbFhCUnFwdVI1enZoamFUOGNPVHBrN2R2UUFWQkd4eHJXSDJJUTFpRTVlbmtsaWhQdVJPcXZPejhydVlQY2h1S21mQ1E3ZE9BNjNZTEFTMWtDNVBkNm5uRHhLemRxNWY2R2d6SUt0clZQTzYyaGhiZlVFVmRCMndqNmpxN19aS0JseTF2MFV3amNR?oc=5","date":"2022-11-29","type":"patent","source":"biocon.com","summary":"Biocon Biologics Completes Acquisition of Viatris’ Global Biosimilars Business - biocon.com","headline":"Biocon Biologics Completes Acquisition of Viatris’ Global Biosimilars Business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxORGZxaG9KdFpKbHJOREdEMkU5STNDcE8xaTY3YnZ4NFlRV2o2cVdrMVY2V1FtR2RyUW9PU25meURFczduQnJMRXo3MUJPLTNDU25wekdtbHJPeGFUUlNzTmpWMUYxc3FnTHhPbGZVWkJ6NTlHRXNwd1VLVTlrZ2VMWjR5QjNjVXZ1NTZNUGM0d25zWFAzXzdJMUZRczA3Y3pzMkNKLVBsMk9WZ2dZa010cnZFbHo2U0t4aFF0U2RvaTRkbWZaRm45VUJwN3VOakFQWHpSLVQ5cmpsUGNVYnFHNkM2bHhoa0RKUWFJWmlCaHMwaTZ6?oc=5","date":"2022-10-27","type":"deal","source":"prnewswire.com","summary":"Geistlich Pharma North America, Inc. acquires Lynch Biologics, LLC, a biologics and tissue engineering company - prnewswire.com","headline":"Geistlich Pharma North America, Inc. acquires Lynch Biologics, LLC, a biologics and tissue engineering company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiSkFVX3lxTE82ZkNJS3NiZnpEZXQyQmdXMElFY2F1UTFkcjY5SFdxdmgzd3VwR1RuMVZDZWQ2bENaZXA3QW9DV3d3ZHM2d0gzbEhn?oc=5","date":"2020-01-11","type":"pipeline","source":"BioInformant","summary":"Exosomes: Company Spotlights from \"A\" to \"Z\" - BioInformant","headline":"Exosomes: Company Spotlights from \"A\" to \"Z\"","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}